14 results about "Alisma plantago" patented technology

This invention relates to the field of traditional Chinese medicine, specifically to a traditional Chinese medicine composition, its preparation method, and its application. The traditional Chinese medicine composition, by weight, comprises the following components: 2-15 parts of ginger-processed Pinellia ternata, 2-15 parts of stir-fried Atractylodes macrocephala, 15-25 parts of Gastrodia elata, 15-25 parts of Poria cocos, 2-15 parts of dried tangerine peel, 5-15 parts of Polyporus umbellatus, 2-15 parts of cinnamon twig, 5-15 parts of Alisma plantago-aquatica, and 1-8 parts of Panax notoginseng powder. This traditional Chinese medicine composition, by combining various components in a specific ratio, allows the components to synergistically work together to achieve the effects of strengthening the spleen and resolving phlegm, promoting diuresis and eliminating turbidity, and calming the liver and unblocking the meridians. Precise proportions and dosages ensure that the entire formula exerts a synergistic effect in improving metabolism, reducing inflammation, and protecting the kidneys, thereby effectively delaying target organ damage while stabilizing blood pressure.

A blood-clearing and lipid-lowering pill is composed of the following ingredients in the indicated weight ratios: Astragalus membranaceus 54-74, Salvia miltiorrhiza 54-74, Paeonia lactiflora 54-74, Carthamus tinctorius 33-53, Pheretima aspergillum 54-74, Hirudo medicinalis 33-53, Crataegus pinnatifida 54-74, Polygonum multiflorum 54-74, Cassia tora 54-74, Gastrodia elata 33-53, Uncaria rhynchophylla 54-74, Eucommia ulmoides 33-53, Achyranthes bidentata 54-74, Os draconis 54-74, Ostrea gigas 54-74, Prunella vulgaris 54-74, and Alisma plantago-aquatica 54-74. This invention can reduce blood viscosity to normal levels in a short period, allowing some patients with vascular stenosis exceeding 75% who require stents to avoid stent grafting, and enabling stroke patients to gradually recover their function.

This invention relates to the field of traditional Chinese medicine preparations, specifically a chewable tablet for adjuvant treatment of myopia and its preparation method, comprising the following raw materials and excipients in parts by weight: Codonopsis pilosula 150-220 parts, Angelica sinensis 150-220 parts, Lycium barbarum 300-500 parts, Poria cocos 40-70 parts, Ophiopogon japonicus 50-80 parts, Alisma plantago-aquatica 35-50 parts, Schisandra chinensis 30-40 parts, Acorus tatarinowii 30-40 parts, Paeonia suffruticosa 35-50 parts, and Polygala tenuifolia (processed with licorice water) 30-40 parts; excipients: mannitol 120-160 parts, sucrose 220- 300 parts, 1-3 parts steviol glycosides, 3-5 parts magnesium stearate, 30-35 parts gastric-soluble film-coating premix, and an appropriate amount of 40-60% ethanol; This invention achieves the effects of tonifying qi and blood, nourishing the liver and kidneys through traditional Chinese medicines such as Codonopsis pilosula, Angelica sinensis, and Lycium barbarum, combined with the effects of Acorus tatarinowii and Polygala tenuifolia in opening the orifices and calming the mind. It has a significant effect on improving vision and relieving eye muscle spasms, especially for myopia, particularly pseudomyopia and eye fatigue in adolescents. The formulation of this invention strictly follows the traditional treatment principles of tonifying qi and blood, nourishing the liver and kidneys, and improving vision and calming the mind. The effective ingredient content is clear and the effect is stable.

This invention belongs to the field of bioengineering technology and provides the application of P450 enzyme in catalyzing the oxidation of squalene. Several cytochrome P450 genes were cloned from the full-length transcriptome data of the medicinal plant *Alisma plantago-aquatica*. Preliminary screening of the gene sequences corresponding to the P450 enzyme was conducted using bioinformatics. Recombinant vectors were prepared using the screened genes and transformed into squalene-producing yeast for gene function verification. This demonstrated the oxidation effect of the P450 enzyme encoded by the AoCYP_3836 gene on squalene, providing a novel reaction mode different from the traditional 2,3-epoxidation reaction of squalene. The results show that the P450 enzyme encoded by the AoCYP_3836 gene can catalyze the oxidation of squalene to produce two new products: squalene-1,1'-diol and squalene-1-carboxylic acid-24-ol, providing a new pathway for the production of these squalene oxides.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and discloses a TCM composition for treating obesity-related hypertension and its preparation method. The composition is made from white ginseng, gynostemma pentaphyllum, Eucommia ulmoides, kudzu root, Atractylodes macrocephala, hawthorn, Alisma plantago-aquatica, Euonymus alatus, Gastrodia elata, Uncaria rhynchophylla, peppermint, and Rhodiola rosea. The preparation process includes a compound enzymatic hydrolysis pretreatment, utilizing cellulase and pectinase to synergistically disrupt cell walls, combined with dual extraction steps of water extraction and alcohol extraction to selectively dissolve components of different polarities. Pharmaceutical excipients are then added to prepare concentrated pills, granules, or tablets. This composition has the effects of invigorating the spleen and replenishing qi, resolving phlegm and eliminating turbidity, and calming the liver and suppressing yang. Through multi-target synergistic action, it achieves simultaneous intervention on blood pressure levels and lipid metabolism, effectively improving metabolic abnormalities in obese patients. The process of this invention reduces mass transfer resistance, increases the transfer rate of total saponins and flavonoids, and results in a product with uniform and stable quality, suitable for large-scale production.

This invention relates to a method for detecting characteristic chromatograms of anti-inflammatory granules or their intermediate extracts, and its application. The anti-inflammatory granules or their intermediate extracts are prepared from the following medicinal ingredients: Astragalus membranaceus, Panax notoginseng, Salvia miltiorrhiza, Paeonia lactiflora, Stephania tetrandra, Alisma plantago-aquatica, Coix lacryma-jobi, Poria cocos, and Achyranthes bidentata. The detection method is high-performance liquid chromatography (HPLC). The HPLC conditions are: an octadecylsilane-bonded silica gel column, acetonitrile as mobile phase A, and phosphoric acid aqueous solution as mobile phase B, with gradient elution. The method of this invention can obtain characteristic chromatograms with high information content and high peak response values. This method can effectively control the key quality attributes of anti-inflammatory granules and is conducive to industrial promotion, which is of great significance for the quality control standards of anti-inflammatory granules.

A herbal medicine composition is provided for treating vertigo and / or dizziness comprising: Alisma orientale rhizome; Atractylodes macrocephala root; Citri reticulatae pericarpium; Citri reticulatae viride pericarpium; and Folium nelumbinis. The vertigo and / or dizziness of present interest should be understood to mean vertigo and / or dizziness arising as a result of water or dampness of the stomach. Methods of treating such vertigo and / or dizziness by administering the herbal medicine composition to a patient in need thereof are also provided.

The application provides a meridian-targeting theory-based traditional Chinese medicine preparation for treating prostatitis and a preparation method thereof. The preparation is composed of eighteen kinds of traditional Chinese medicines, including plantago seed, alisma orientalis, phellodendron, taraxacum, salvia miltiorrhiza, cyathula officinalis, eucommia ulmoides and epimedium etc. The cyathula officinalis, plantago seed and alisma orientalis are used as meridian-leading drugs to guide the active ingredients to flow down along the liver meridian of foot-Jueyin, the kidney meridian of foot-Shaoyin and the bladder meridian of foot-Taiyang, and target the prostate region. The whole preparation has the effects of clearing heat and reducing dampness, promoting blood circulation to remove blood stasis, soothing liver and regulating qi and tonifying kidney and consolidating the foundation, and is suitable for chronic prostatitis and benign prostatic hyperplasia of the type of lower-heat and kidney deficiency and blood stasis. The preparation can be prepared into various dosage forms such as capsules, granules and oral liquid. Experiments show that the preparation can significantly improve the urination symptoms and reduce the inflammation and fibrosis of the prostate, and has the advantages of strong targeting, definite curative effect, high safety and long-term use.

Abstract: This invention discloses a traditional Chinese medicine composition (Da Zhuque Decoction) with multi-target antiviral and anti-inflammatory activities, its preparation method, and its application. The composition consists of the following raw materials in parts by weight: Alisma plantago-aquatica 2-4 parts, Prunus armeniaca 4-6 parts, Chrysanthemum indicum 4-6 parts, Artemisia annua 5-7 parts, Morus alba leaf 5-7 parts, Gypsum 5-7 parts, Poria cocos 7-9 parts, Scutellaria baicalensis 8-10 parts, Rehmannia glutinosa 8-10 parts, Plantago asiatica 11-13 parts, Taraxacum mongolicum 14-16 parts, and Glycyrrhiza uralensis 3-5 parts. This invention overcomes the limitations of traditional qualitative formulation of traditional Chinese medicines. By limiting the specific synergistic ratio of artemisinin and baicalin (1:2.5~3.0), it achieves highly efficient inhibition of respiratory viruses (IC50=12.5μg / mL) and significant downregulation of inflammatory factors (IL-6, TNF-α). Meanwhile, the preparation process of "plaster decoction first - licorice extraction alone" solves the problem of easy decomposition of heat-sensitive components, increasing the artemisinin retention rate to over 95%. This invention has a clear material basis, controllable quality, and is suitable for preparing drugs or health products for the prevention and treatment of viral pneumonia.

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a traditional Chinese medicine composition for treating atherosclerosis, its preparation method, and application. The traditional Chinese medicine composition for treating atherosclerosis consists of the following raw materials in parts by weight: 4-15 parts of prepared aconite root, 4-15 parts of ephedra, 20-40 parts of poria cocos, 10-20 parts of cudweed, 10-20 parts of pinellia ternata, 5-15 parts of alisma plantago-aquatica, 4-15 parts of rhubarb (processed with wine), and 10-20 parts of angelica dahurica. This traditional Chinese medicine composition for treating atherosclerosis can achieve comprehensive intervention on atherosclerosis through a dual-target mechanism of "metabolic regulation + anti-inflammatory effect." By reducing serum inflammatory response, improving lipid deposition in the aortic intima, and reducing plaque thickening, it has significant therapeutic effects and good safety in treating atherosclerosis-related tissue inflammatory damage, and has high application value and promising prospects for promotion.

The application discloses a kind of treating wind heat type eczema's Qufeng Zhiyang granules, contain bamboo leaf 30-50 parts, Ophiopogon 20-30 parts, Huangqi 15-25 parts, Cape jasmine 20-30 parts, Lily 15-25 parts, Shengdi 20-30 parts, Lianqiao 18-22 parts, Honeysuckle 20-30 parts, Xuan 20-30 parts, Purple grass 18-22 parts, Alisma 15-25 parts, Plantago 20-30 parts, Fuling 18-22 parts, Baizhu 15-25 parts, Guizhi 10-20 parts, Amomum 18-22 parts, Red flower 20-30 parts, Red Shaor 15-25 parts, Tao Ren 18-22 parts, Danshen 15-25 parts, Huangqi 20-30 parts, Dangshen 20-30 parts, Jiegeng 15-25 parts, Banxia 15-25 parts, can clear heart fire, blood detoxification, dispel wind and clear heat and dampness, spleen dampness, blood circulation, lung qi, lung yin, lung, wind heat type eczema treatment, effect is remarkable, and its preparation method is disclosed.

The application discloses a harvest machine for alisma orientalis, and relates to the technical field of alisma orientalis harvesting.The one end of a rack is fixedly connected with a connecting frame at the top, a gearbox is arranged at the one end of the rack, transmission chains are respectively in transmission connection between the two sides of the gearbox and conveying mechanisms and beating mechanisms, an adjusting mechanism is rotationally connected on the rack, and one end of a protection mechanism is penetrated by the adjusting mechanism, so that the protection mechanism is adjusted in lifting, the adjusting mechanism adopts screw rod lifting, is matched with an inclined conveying mechanism, the distance between the beating mechanism and the inclined conveying mechanism can be widely adjusted, the beating strength can be controlled and adjusted in a large range, and the application range of the machine is improved.

The application discloses a kind of acne-removing compositions, including Baiji, Huanglian, dandelion, spironolactone, borneol, alisma, purple flower diting, baiyan, the effective component extract of composition formed by white yam;Wherein the weight ratio of each component is: Baiji 10.0~12.0%, Huanglian 3.0~4.5%, dandelion 14.0~16.0%, spironolactone 14.0~16.0%, borneol 7.0~8.5%, alisma 7.0~8.5%, purple flower diting 14.0~16.0%, baiyan 14.0~16.0%, white yam 10.0~12.0%.The application compared with prior art has the advantages that: provide a kind of acne-removing compositions capable of repairing damaged skin, suitable for a variety of external preparation forms and preparation method and application.

This invention belongs to the field of pet urinary health technology, and specifically relates to a medicinal and edible homologous composition for improving pet urinary health. The composition comprises: Alisma plantago-aquatica, Poria cocos, celery seed, winter melon peel, and Juncus effusus, with a mass ratio of (4-6):(3-5):(2-4):(1-3):(0.5-1.5). This invention's medicinal and edible homologous composition is based on a systematic formulation concept, is scientifically sound, and selects medicinal and edible homologous raw materials with diuretic, urination-clearing, and water metabolism-regulating effects. The components work synergistically, significantly enhancing diuresis and urination efficiency, thus helping to improve the urinary health of pets.